181
Views
10
CrossRef citations to date
0
Altmetric
Original Research

Delayed Breast Cancer Detection in an Asian Country (Taiwan) with Low COVID-19 Incidence

ORCID Icon &
Pages 5899-5906 | Published online: 28 Jul 2021

References

  • Cheng HY, Jian S-W, Liu D-P, et al. Contact tracing assessment of COVID-19 transmission dynamics in taiwan and risk at different exposure periods before and after symptom onset. JAMA Intern Med. 2020;180(9):1156–1163. doi:10.1001/jamainternmed.2020.202032356867
  • Wang CJ, Ng CY, Brook RH. Response to COVID-19 in Taiwan: big data analytics, new technology and Proactive Testing. JAMA. 2020;323(14):1341–1342.32125371
  • Chang HJ, Huang N, Lee C-H, et al. The impact of the SARS epidemic on the utilization of medical services: SARS and the fear of SARS. Am J Public Health. 2004;94(4):562–564. doi:10.2105/AJPH.94.4.56215054005
  • Chou CP, Pan H-B, Hsu G-C, et al. Assessing the first 3 years of Taiwan’s nationwide population-based mammography screening program. Breast J. 2012;18(5):498–499. doi:10.1111/j.1524-4741.2012.01289.x22897616
  • Yen AM, Tsau HS, Fann JC, et al. Population-based breast cancer screening with risk-based and universal mammography screening compared with clinical breast examination: a propensity score analysis of 1429890 Taiwanese women. JAMA Oncol. 2016;2(7):915–921. doi:10.1001/jamaoncol.2016.044727030951
  • Chou CP, Pan HB, Yang TL, et al. Impact of the COVID-19 pandemic on the volume of mammography examinations in Southern Taiwan. Breast J. 2020. doi:10.1111/tbj.14019[Epub ahead of print]
  • Ward WH, DeMora L, Handorf E, et al. Preoperative delays in the treatment of DCIS and the associated incidence of invasive breast cancer. Ann Surg Oncol. 2020;27(2):386–396. doi:10.1245/s10434-019-07844-431562602
  • Huo Q, Cai C, Zhang Y, et al. Delay in diagnosis and treatment of symptomatic breast cancer in China. Ann Surg Oncol. 2015;22(3):883–888. doi:10.1245/s10434-014-4076-925212834
  • Taiwan Centers for Disease Control Daily press release of COVID-19. Available from: https://www.cdc.gov.tw/En. Accessed 621, 2020.
  • Giuliano AE, Edge SB, Hortobagyi GN. Eighth Edition of the AJCC cancer staging manual: breast cancer. Ann Surg Oncol. 2018;25(7):1783–1785. doi:10.1245/s10434-018-6486-629671136
  • Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. New York: Routledge; 2013:567.
  • Akoglu H. User’s guide to correlation coefficients. Turk J Emerg Med. 2018;18(3):91–93. doi:10.1016/j.tjem.2018.08.00130191186
  • Peng S-M, Yang K-C, Chan WP, et al. Impact of the COVID-19 pandemic on a population-based breast cancer screening program. Cancer. 2020;126(24):5202–5205. doi:10.1002/cncr.3318032914864
  • Sud A, Torr B, Jones ME, et al. Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study. Lancet Oncol. 2020;21(8):1035–1044. doi:10.1016/S1470-2045(20)30392-232702311
  • Kaufman HW, Chen Z, Niles J, et al. Changes in the number of US patients with newly identified cancer before and during the coronavirus disease 2019 (COVID-19) pandemic. JAMA Netw Open. 2020;3(8):e2017267. doi:10.1001/jamanetworkopen.2020.1726732749465
  • Dinmohamed AG, Visser O, Verhoeven RHA, et al. Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands. Lancet Oncol. 2020;21(6):750–751. doi:10.1016/S1470-2045(20)30265-532359403
  • Richards MA, Westcombe AM, Love SB, et al. Influence of delay on survival in patients with breast cancer: a systematic review. Lancet. 1999;353(9159):1119–1126. doi:10.1016/S0140-6736(99)02143-110209974
  • Tartter PI, Pace D, Frost M, et al. Delay in diagnosis of breast cancer. Ann Surg. 1999;229(1):91–96. doi:10.1097/00000658-199901000-000129923805
  • Curigliano G, Cardoso MJ, Poortmans P, et al. Recommendations for triage, prioritization and treatment of breast cancer patients during the COVID-19 pandemic. Breast. 2020;52:8–16. doi:10.1016/j.breast.2020.04.00632334323
  • Dietz JR, Moran MS, Isakoff SJ, et al. Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic. the COVID-19 pandemic breast cancer consortium. Breast Cancer Res Treat. 2020;181(3):487–497. doi:10.1007/s10549-020-05644-z32333293
  • Moy L, Toth HK, Newell MS, et al. Response to COVID-19 in breast imaging. J Breast Imaging. 2020;2(3):180–185. doi:10.1093/jbi/wbaa025
  • Papautsky EL, Hamlish T. Patient-reported treatment delays in breast cancer care during the COVID-19 pandemic. Breast Cancer Res Treat. 2020;184(1):249–254. doi:10.1007/s10549-020-05828-732772225
  • Maringe C, Spicer J, Morris M, et al. The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based modelling study. Lancet Oncol. 2020;21(8):1023–1034. doi:10.1016/S1470-2045(20)30388-032702310
  • The American Society of Breast Surgeons. ASBrS and ACR joint statement on breast screening exams during the COVID-19 pandemic; 2020. Available from: https://www.breastsurgeons.org/news/?id=45. 1124, 2020.
  • Shim E, Tariq A, Choi W, et al. Transmission potential and severity of COVID-19 in South Korea. Int J Infect Dis. 2020;93:339–344. doi:10.1016/j.ijid.2020.03.03132198088
  • Smith BL, Nguyen A, Korotkin JE, et al. A system for risk stratification and prioritization of breast cancer surgeries delayed by the COVID-19 pandemic: preparing for re-entry. Breast Cancer Res Treat. 2020;183(3):515–524. doi:10.1007/s10549-020-05792-232712878